Abstract
Infection of an aortic prosthesis presents a diagnostic and therapeutic challenge. Fungal infections are rarely described and among these Candida spp. are the most prevalent agents. Although the therapeutic approach to prosthetic bacterial infection may be conservative, in the case of fungal etiology, surgery, such as the removal and substitution of the device, debridement and repair of the infected prosthesis is usually warranted. The authors describe the case of a 48-year-old man, with a thoraco-abdominal aneurysm of the aorta, submitted to surgery for insertion of a prosthetic aortic duct. The procedure was made difficult by Candida albicans empyema associated with an aortic prosthesis infection that was complicated by probable cerebral metastasis. Antifungal therapy was the initial option, as the steady clinical, laboratory and radiological improvement deferred a surgical intervention. This case demonstrates the success of a conservative approach in a very serious fungal infection of a thoraco-abdominal aorta prosthesis.
Similar content being viewed by others
References
Kitamura T, Morota T, Motomura N, et al. Management of infected grafts and aneurysms of the aorta. Ann Vasc Surg. 2005;19:335–42.
Mathes DW, Yaremchuk MJ, Isselbacher EM, Madsen JC. Successful in situ treatment of an infected ascending aortic graft. Ann Thorac Surg. 2000;70:1410–2.
Bakoyiannis CN, Georgopoulos SE, Tsekouras NS, Klonaris CN, Papalambros EL, Bastounis EA. Fungal infection of aortoiliac endograft: a case report and review of the literature. Ann Vasc Surg. 2007;21:228–31.
Collazos J, Mayo J, Martínez E, Ibarra S. Prosthetic vascular graft infection due to Aspergillus species: case report and literature review. Eur J Clin Microbiol Infect Dis. 2001;20:414–7.
Pappas PG, Kauffman C, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Disease Society of America. Clin Infect Dis. 2009;48:503–35.
Coselli JS, Koksoy C, LeMaire SA. Management of thoracic aortic graft infections. Ann Thorac Surg. 1996;67:1990–3.
Antidulafungin prescribing information; Pfizer Inc NY. 2006. http://www.pfizer.com/pfizer/download/uspi_eraxis.pdf. Accessed June 22 2012.
Kethireddy S, Andes D. CNS pharmacokinetics of antifungal agents. Expert Opin Drug Metab Toxicol. 2007;3:573–81.
Disclosures
This manuscript has been published in a journal supplement that was created with an unrestricted educational grant from Gilead Portugal. The authors have no conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guedes, A.M., de Macedo, T.A., Rocha, C. et al. Early Fungal Infection in an Aortic Prosthesis with Probable Cerebral Metastasis: The Success of a Conservative Strategy. Clin Drug Investig 33 (Suppl 1), 41–45 (2013). https://doi.org/10.1007/s40261-012-0020-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40261-012-0020-6